Tag Archives: Parkinson’s Disease

Two European Parkinson’s studies kick off 2018 with promising discoveries; proof to me, for example, that not all biotech worth noting come from the USA.

The News: A combination therapy made up of two neurotrophic factors has been shown in a report to reduce the degenerative effects of Parkinson’s disease, report researchers from the UPV/EHU-University… Read more »

Want to ward off dementia; cut Parkinson’s progression? Exercise, exercise, exercise–and the harder the better, new study reports.

The News: High-intensity exercise three times a week is safe for individuals with early-stage Parkinson’s disease and decreases worsening of motor symptoms, according to a new Phase 2, multi-site trial… Read more »

New Biogen pick for CEO inherits tough job; markets aren’t exactly enthralled–yet

Biogen Inc. (Cambridge MA) said Monday (December 19, 2016) it has named veteran biopharmaceutical executive Michel Vounatsos, head of the company’s commercial organization, its next chief executive. Mr. Vounatsos will succeed George Scangos, who announced earlier this… Read more »